Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Karam

Showing results (61-70 of 468) with videos related to

Pageof 47
Sort By:
Urology|April 10, 2004
Prostate-specific antigen doubling time predicts response to deferred antiandrogen therapy in men with androgen-independent prostate cancerMichael J Shulman, Jose A Karam, Elie A Benaim
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 27, 2014
Treating the two extremes in renal cell carcinoma: management of small renal masses and cytoreductive nephrectomy in metastatic diseaseDae Y Kim, Christopher G Wood, Jose A Karam
Journal of Pediatric Urology|March 24, 2009
Pediatric hemorrhagic cystitisDaniel B Decker, Jose A Karam, Duncan T Wilcox
Southern Medical Journal|March 1, 1995
Vaginal eviscerationJ A Karam, P A Wengert, M D Kerstein
Annales De Dermatologie Et De Venereologie|April 27, 2010
[Topical steroids in the treatment of paronychia induced by the epidermal growth factor receptor inhibitor cetuximab]N Coquart, A Karam, J-P Metges, et al.
Future Oncology (London, England)|July 31, 2007
Blood biomarkers for prostate cancer detection and prognosisShahrokh F Shariat, Jose A Karam, Claus G Roehrborn
Prostate Cancer and Prostatic Diseases|March 5, 2004
Impact of training level of urology residents on the detection of prostate cancer on TRUS biopsyJ A Karam, M J Shulman, E A Benaim
Genetic Testing and Molecular Biomarkers|August 26, 2022
Long Noncoding RNA NEAT1 Expression and Its Target miR-124 in Diabetic Ischemic Stroke PatientsRehab A Karam, Mona M Amer, Haidy E Zidan
Biomarkers in Medicine|May 19, 2010
Urine cytology and urine-based markers for bladder urothelial carcinoma detection and monitoring: developments and future prospectsShahrokh F Shariat, Jose A Karam, Jay D Raman
European Urology|January 6, 2010
Words of wisdom. Re: Temsirolimus, interferon alfa, or both for advanced renal-cell carcinoma. Hudes G, Carducci M, Tomczak P, Dutcher J, Figlin R, Kapoor A, Staroslawska E, Sosman J, McDermott D, Bodrogi I, Kovacevic Z, Lesovoy V, Schmidt-Wolf IG, Barbarash O, Gokmen E, O'Toole T, Lustgarten S, Moore L, Motzer RJ; Global ARCC Trial. N Engl J Med 2007;356:2271-81Shahrokh F Shariat, Jose A Karam, Pierre I Karakiewicz
Pageof 47

Showing results (61-70 of 468) with videos related to

Sort By:
Pageof 47
Urology|April 10, 2004
Prostate-specific antigen doubling time predicts response to deferred antiandrogen therapy in men with androgen-independent prostate cancerMichael J Shulman, Jose A Karam, Elie A Benaim
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 27, 2014
Treating the two extremes in renal cell carcinoma: management of small renal masses and cytoreductive nephrectomy in metastatic diseaseDae Y Kim, Christopher G Wood, Jose A Karam
Journal of Pediatric Urology|March 24, 2009
Pediatric hemorrhagic cystitisDaniel B Decker, Jose A Karam, Duncan T Wilcox
Southern Medical Journal|March 1, 1995
Vaginal eviscerationJ A Karam, P A Wengert, M D Kerstein
Annales De Dermatologie Et De Venereologie|April 27, 2010
[Topical steroids in the treatment of paronychia induced by the epidermal growth factor receptor inhibitor cetuximab]N Coquart, A Karam, J-P Metges, et al.
Future Oncology (London, England)|July 31, 2007
Blood biomarkers for prostate cancer detection and prognosisShahrokh F Shariat, Jose A Karam, Claus G Roehrborn
Prostate Cancer and Prostatic Diseases|March 5, 2004
Impact of training level of urology residents on the detection of prostate cancer on TRUS biopsyJ A Karam, M J Shulman, E A Benaim
Genetic Testing and Molecular Biomarkers|August 26, 2022
Long Noncoding RNA NEAT1 Expression and Its Target miR-124 in Diabetic Ischemic Stroke PatientsRehab A Karam, Mona M Amer, Haidy E Zidan
Biomarkers in Medicine|May 19, 2010
Urine cytology and urine-based markers for bladder urothelial carcinoma detection and monitoring: developments and future prospectsShahrokh F Shariat, Jose A Karam, Jay D Raman
European Urology|January 6, 2010
Words of wisdom. Re: Temsirolimus, interferon alfa, or both for advanced renal-cell carcinoma. Hudes G, Carducci M, Tomczak P, Dutcher J, Figlin R, Kapoor A, Staroslawska E, Sosman J, McDermott D, Bodrogi I, Kovacevic Z, Lesovoy V, Schmidt-Wolf IG, Barbarash O, Gokmen E, O'Toole T, Lustgarten S, Moore L, Motzer RJ; Global ARCC Trial. N Engl J Med 2007;356:2271-81Shahrokh F Shariat, Jose A Karam, Pierre I Karakiewicz
Pageof 47